Search Results for: Cambrex Invests in Generic API
Articles
October 12, 2017
Cambrex Invests in Generic API Development & Manufacturing Capabilities at its Milan Site October 12, 2017
Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), recently announced that it has...
August 14, 2017
Cambrex Invests $24 Million in New Highly Potent API Manufacturing Capacity August 14, 2017
Cambrex Corporation recently announced it is to invest $24 million in a new facility to manufacture highly potent APIs (HPAPIs)...
June 6, 2017
Cambrex Invests in New Capacity & Continuous Flow Technology June 6, 2017
Cambrex Corporation recently announced it has expanded large-scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden, and has introduced...
